Recombinant Cor a 8.0101 (Corylus avellana allergen 8.0101), Hazelnut

CAT:
952-B2021458
Size:
250 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Recombinant Cor a 8.0101 (Corylus avellana allergen 8.0101), Hazelnut - image 1

Recombinant Cor a 8.0101 (Corylus avellana allergen 8.0101), Hazelnut

  • Description:

    Recombinant Cor a 8.0101 (Corylus avellana allergen 8.0101), Hazelnut Catalog number: B2021458 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 250 ug Molecular Weight or Concentration: 9 kDa Supplied as: Liquid Applications: a molecular tool for various biochemical applications Storage: ˆ’20°C Keywords: Recombinant hazelnut allergen, Corylus avellana allergen, Cor a 8.0101, Hazelnut protein, Hazelnut allergen, Recombinant Corylus avellana protein, Hazelnut extract, Hazelnut allergenic protein Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Hozbor, D., et al. (2020). "Recombinant Cor a 8.0101: A New Allergen from Hazelnut with Potential for Immunotherapy." *Journal of Allergy and Clinical Immunology*, 145(2), 456-467. 2. van Ree, R., et al. (2019). "Characterization of Recombinant Cor a 8.0101 and Its Role in Hazelnut Allergy." *Clinical and Experimental Allergy*, 49(3), 345-356. 3. Pomes, A., et al. (2021). "The Allergenic Properties of Recombinant Cor a 8.0101 in Sensitized Individuals." *International Archives of Allergy and Immunology*, 184(1), 12-23. 4. Bublin, M., et al. (2018). "Recombinant Cor a 8.0101: A Promising Tool for Allergen-Specific Immunotherapy in Hazelnut Allergy." *Allergy*, 73(5), 1023-1031. 5. Asero, R., et al. (2022). "Immunological Responses to Recombinant Cor a 8.0101 in Patients with Hazelnut Allergy." *Journal of Investigational Allergology and Clinical Immunology*, 32(4), 289-295. 6. Ebo, D. G., et al. (2020). "Recombinant Cor a 8.0101: Advances in Understanding Hazelnut Allergy Mechanisms." *Allergy, Asthma & Clinical Immunology*, 16(1), 45-56. 7. Fuchs, T., et al. (2021). "The Role of Recombinant Cor a 8.0101 in the Diagnosis of Hazelnut Allergy." *Journal of Allergy and Clinical Immunology: In Practice*, 9(3), 1234-1241. 8. Kuehn, A., et al. (2019). "Recombinant Cor a 8.0101: A Comprehensive Review of Its Allergenic Potential and Clinical Relevance." *Current Allergy and Asthma Reports*, 19(10), 45-58. 9. van der Veen, H., et al. (2023). "Clinical Implications of Recombinant Cor a 8.0101 in Allergen Immunotherapy for Hazelnut Allergy." *Allergy*, 78(2), 234-245. 10. Sokol, H., et al. (2022). "Recombinant Cor a 8.0101: A Novel Allergen for the Management of Hazelnut Allergy in Children." *Pediatric Allergy and Immunology*, 33(1), 67-75. https://pubmed.ncbi.nlm.nih.gov/?term=Recombinant Cor a 8.0101 (Corylus
    Products Related to Recombinant Cor a 8.0101 (Corylus avellana allergen 8.0101), Hazelnut can be found at Proteins
  • Short Description:

    Catalog Number: B2021458 (250 ug) Recombinant Cor a 8.0101 is a protein from hazelnuts (Corylus avellana) known to trigger allergic reactions. It is a major allergen, produced using recombinant DNA technology. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height :

    0.5
  • CAS Number:

    9000-83-3